Drug delivery

Biotechnology company Calidi Biotherapeutics has been granted a US patent for its SuperNova (SNV) technology platform. Calidi’s SNV platform is composed of allogeneic, adipose-derived mesenchymal stem cells (AD-MSC) loaded with an oncolytic agent. The company aims to use it in combination with various immunotherapy agents, including blocking antibodies. The SNV platform is designed to shield oncolytic viral payloads from the immune system, potentially delivering immuno-oncology […]

Biotech ISA Pharmaceuticals has launched a clinical trial using its Amplivant adjuvant technology which will enable the delivery of a cancer vaccine in patients.  The clinical trial, run by partner Scancell Holdings, is a multicentre clinical trial testing Scancell’s Modi-1 vaccine in patients with triple negative breast cancer, ovarian cancer, head and neck cancer, and […]

Jackson ImmunoResearch, manufacturers of secondary antibodies and immunoreagents for the life science market, has announced a new range of detection reagents for improved image quality.  Nano Secondaries   Jackson ImmunoResearch Nano Secondaries are polyclonal VHH Fragment antibodies (Nanobodies*) produced in Alpacas. They are available with specificity to human, rabbit, or mouse. Ten times smaller than conventional […]

The Bloomsbury SET – a knowledge exchange programme led by the UK’s Royal Veterinary College (RVC) – has announced a Commercialisation Pilot of 12 new grants for projects which will develop tools to better fight infectious disease or antimicrobial resistance (AMR). Supported by more than £1 million of funding, these projects will bring together researchers and businesses to deliver new vaccines, diagnostics and […]

TetraScience resolves root cause scientific data problems with a cloud-native platform, purpose-built to benefit scientists and data scientists, who use Tetra Data for automation and ML/AI. This paid-for advertorial by TetraScience appeared in the DDW / SLAS supplement in DDW Volume 23, Issue 1 – Winter 2021/22  Technology drives the value of scientific inquiry and outcomes. There continues to be brilliant […]

After decades of research, the UK implemented a human papillomavirus (HPV) vaccine programme for teenage girls in 2008. Now, for the first time, a study has shown that the UK HPV vaccine programme works and will save lives, according to research funded by Cancer Research UK.  The vaccine was shown to dramatically reduce cervical cancer rates by almost 90% […]

The Cell and Gene Therapy Catapult (CGT Catapult) and Deep Science Ventures have partnered to address barriers in the ATMP industry, create new companies and deliver better patient outcomes.  Recent advances in cell and gene therapies promise potential cures to devastating diseases. However, major hurdles still need to be overcome, including ensuring target specificity and effective manufacturing […]

Grant Cameron, Director at Clydeworth Consulting, examines the benefits of process intensification and highlights the steps which will improve process productivity, reduce environmental impact and decrease the cost of therapy manufacture while maintaining product quality.  The move to continuous bioprocessing has been a major topic for a number of years however, challenges remain despite technological and regulatory […]

Abcam has completed a $340m strategic acquisition of BioVision and doubled the footprint of its immunoassay kit R&D and manufacturing facility in Eugene, Oregon. This enhanced capacity is another component of Abcam’s growth in the US, which the company says will enable it to support the research and biopharma sector globally.  The addition of BioVision enhances Abcam’s […]

  This paid-for whitepaper by The SiLA (Standardization in Lab Automation) consortium appeared in DDW Volume 22, Issue 4 – Fall 2021  R&D, manufacturing and contract research laboratories across many industries are investing in efforts to digitalise their processes and operations, with the goal of achieving end-to-end connectivity and automation. A common aim is to […]